CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 74 filers reported holding CASI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $14,000 | -56.2% | 16,983 | -36.4% | 0.00% | – |
| Q3 2021 | $32,000 | +357.1% | 26,715 | +493.1% | 0.00% | – |
| Q2 2021 | $7,000 | -84.4% | 4,504 | -76.0% | 0.00% | – |
| Q1 2021 | $45,000 | +4.7% | 18,777 | +27.5% | 0.00% | – |
| Q4 2020 | $43,000 | +514.3% | 14,731 | +207.2% | 0.00% | – |
| Q3 2020 | $7,000 | -83.7% | 4,796 | -72.0% | 0.00% | – |
| Q2 2020 | $43,000 | -29.5% | 17,158 | -42.2% | 0.00% | – |
| Q1 2020 | $61,000 | -70.5% | 29,673 | -55.8% | 0.00% | – |
| Q4 2019 | $207,000 | +48.9% | 67,101 | +61.5% | 0.00% | – |
| Q3 2019 | $139,000 | +215.9% | 41,561 | +206.0% | 0.00% | – |
| Q2 2019 | $44,000 | +528.6% | 13,580 | +504.1% | 0.00% | – |
| Q1 2019 | $7,000 | -92.2% | 2,248 | -89.9% | 0.00% | – |
| Q4 2018 | $90,000 | +47.5% | 22,293 | +71.1% | 0.00% | – |
| Q3 2018 | $61,000 | -46.0% | 13,027 | -5.5% | 0.00% | – |
| Q2 2018 | $113,000 | +391.3% | 13,781 | +156.5% | 0.00% | – |
| Q1 2018 | $23,000 | -34.3% | 5,373 | -50.6% | 0.00% | – |
| Q4 2017 | $35,000 | +600.0% | 10,872 | +351.3% | 0.00% | – |
| Q3 2017 | $5,000 | -37.5% | 2,409 | -68.3% | 0.00% | – |
| Q2 2017 | $8,000 | +300.0% | 7,598 | +488.5% | 0.00% | – |
| Q1 2017 | $2,000 | -50.0% | 1,291 | -57.9% | 0.00% | – |
| Q4 2016 | $4,000 | +300.0% | 3,064 | +251.4% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 872 | -38.0% | 0.00% | – |
| Q2 2016 | $2,000 | -60.0% | 1,407 | -70.3% | 0.00% | – |
| Q1 2016 | $5,000 | +66.7% | 4,735 | +64.9% | 0.00% | – |
| Q4 2015 | $3,000 | -66.7% | 2,872 | -64.6% | 0.00% | – |
| Q3 2015 | $9,000 | +80.0% | 8,103 | +165.6% | 0.00% | – |
| Q2 2015 | $5,000 | +25.0% | 3,051 | +6.2% | 0.00% | – |
| Q1 2015 | $4,000 | -42.9% | 2,872 | -42.1% | 0.00% | – |
| Q4 2014 | $7,000 | – | 4,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |